JPS58213710A - 坐剤組成物 - Google Patents
坐剤組成物Info
- Publication number
- JPS58213710A JPS58213710A JP9538982A JP9538982A JPS58213710A JP S58213710 A JPS58213710 A JP S58213710A JP 9538982 A JP9538982 A JP 9538982A JP 9538982 A JP9538982 A JP 9538982A JP S58213710 A JPS58213710 A JP S58213710A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- hydrophilic
- acid glyceride
- base
- containing compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 239000000829 suppository Substances 0.000 title abstract description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- 239000000194 fatty acid Substances 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims abstract description 9
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229960001138 acetylsalicylic acid Drugs 0.000 claims abstract description 7
- MXRIRQGCELJRSN-UHFFFAOYSA-N O.O.O.[Al] Chemical compound O.O.O.[Al] MXRIRQGCELJRSN-UHFFFAOYSA-N 0.000 claims abstract description 6
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960001680 ibuprofen Drugs 0.000 claims abstract description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract 2
- 229960002390 flurbiprofen Drugs 0.000 claims abstract 2
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims abstract 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims abstract 2
- 229960000991 ketoprofen Drugs 0.000 claims abstract 2
- 150000002433 hydrophilic molecules Chemical class 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 9
- 230000001754 anti-pyretic effect Effects 0.000 abstract description 5
- 239000002221 antipyretic Substances 0.000 abstract description 5
- 230000000202 analgesic effect Effects 0.000 abstract description 4
- 238000003780 insertion Methods 0.000 abstract description 4
- 230000037431 insertion Effects 0.000 abstract description 4
- 238000002844 melting Methods 0.000 abstract description 4
- 230000008018 melting Effects 0.000 abstract description 4
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 230000000638 stimulation Effects 0.000 abstract 2
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 abstract 1
- -1 analgesic Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 229960002009 naproxen Drugs 0.000 abstract 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 abstract 1
- 230000001376 precipitating effect Effects 0.000 abstract 1
- 238000007493 shaping process Methods 0.000 abstract 1
- 230000007794 irritation Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 239000002075 main ingredient Substances 0.000 description 8
- 239000000654 additive Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000730 antalgic agent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 229940035676 analgesics Drugs 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000000622 irritating effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 238000004898 kneading Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229910002012 Aerosil® Inorganic materials 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N Calcium oxide Chemical group [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 244000146493 Cryptotaenia japonica Species 0.000 description 1
- 235000004035 Cryptotaenia japonica Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 230000000274 adsorptive effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940125716 antipyretic agent Drugs 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9538982A JPS58213710A (ja) | 1982-06-03 | 1982-06-03 | 坐剤組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9538982A JPS58213710A (ja) | 1982-06-03 | 1982-06-03 | 坐剤組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58213710A true JPS58213710A (ja) | 1983-12-12 |
| JPH0153644B2 JPH0153644B2 (enrdf_load_stackoverflow) | 1989-11-15 |
Family
ID=14136289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9538982A Granted JPS58213710A (ja) | 1982-06-03 | 1982-06-03 | 坐剤組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58213710A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4732753A (en) * | 1984-02-22 | 1988-03-22 | Hoffmann-La Roche Inc. | Suppository dosage form |
| WO1997045122A1 (fr) * | 1996-05-31 | 1997-12-04 | Kanebo, Limited | Suppositoires |
-
1982
- 1982-06-03 JP JP9538982A patent/JPS58213710A/ja active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4732753A (en) * | 1984-02-22 | 1988-03-22 | Hoffmann-La Roche Inc. | Suppository dosage form |
| WO1997045122A1 (fr) * | 1996-05-31 | 1997-12-04 | Kanebo, Limited | Suppositoires |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0153644B2 (enrdf_load_stackoverflow) | 1989-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bedse | Drug delivery on rectal absorption: suppositories | |
| JPS6042766B2 (ja) | 基剤 | |
| JPH09328427A (ja) | 新規なフェノフィブラート含有製薬用組成物及びそれらの用途 | |
| CN1196477C (zh) | 用于口服给药的药物组合物 | |
| JPH08253411A (ja) | 軟質ゼラチン医薬製剤 | |
| US3440320A (en) | Chelated suppository and method of using same | |
| JPS58152810A (ja) | イブプロフエン含有外用薬剤及びその製造方法 | |
| JP2016094462A (ja) | ソフトゲルカプセル化のためのナプロキセンの医薬処方およびその組合せ | |
| JP4128524B2 (ja) | 体温上昇性アミノ酸群飲食用及び医療用の剤 | |
| TWI285115B (en) | Fill liquid composition for ibuprofen capsule and capsule preparation | |
| JPS62298530A (ja) | 坐薬用医薬組成物 | |
| Kumar et al. | Modern aspects of suppositories: A review | |
| JP3382076B2 (ja) | イブプロフェンを溶解してなるかぜ薬軟カプセル及びその製造方法 | |
| JP3496158B2 (ja) | トラネキサム酸配合ゼラチンカプセル製剤 | |
| JPS58213710A (ja) | 坐剤組成物 | |
| CN102000341B (zh) | 在栓剂组合物中的聚氧化乙烯及基质型表面活性剂 | |
| JP4124495B2 (ja) | 局所麻酔組成物 | |
| KR19990087178A (ko) | 병변조직 치료용 외용약제 | |
| Etman et al. | Emulsions and rectal formulations containing myrrh essential oil for better patient compliance | |
| TW575434B (en) | A pharmaceutical mixture comprising a profen | |
| JPS601281B2 (ja) | 坐剤 | |
| KR100740015B1 (ko) | 가용화된 탈니플루메이트의 연질캡슐제 조성물 및 그의제조방법 | |
| JPS63179820A (ja) | 坐剤組成物 | |
| JPH06298667A (ja) | 徐放性坐剤 | |
| KR20050019198A (ko) | 가용성 덱시부프로펜의 연질캅셀제 조성물 및 그의 제조방법 |